Westchester Capital Management (New York)’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,029
| Closed | -$397K | – | 229 |
|
|
2024
Q1 | $397K | Hold |
36,029
| – | – | 0.01% | 163 |
|
|
2023
Q4 | $393K | Hold |
36,029
| – | – | 0.01% | 190 |
|
|
2023
Q3 | $420K | Buy |
+36,029
| New | +$420K | 0.01% | 217 |
|
|
2023
Q2 | – | Sell |
-763,676
| Closed | -$8M | – | 328 |
|
|
2023
Q1 | $8M | Buy |
763,676
+707,176
| +1,252% | +$7.41M | 0.24% | 118 |
|
|
2022
Q4 | $582K | Buy |
+56,500
| New | +$582K | 0.02% | 345 |
|